Population exposure-response modeling of metformin in patients with type 2 diabetes mellitus.
about
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusPopulation PK/PD analysis of metformin using the signal transduction model.Let Visuals Tell the Story: Medication Adherence in Patients with Type II Diabetes Captured by a Novel Ingestion Sensor Platform.Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects.Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials.Effects of SLC22A1 Polymorphisms on Metformin-Induced Reductions in Adiposity and Metformin Pharmacokinetics in Obese Children With Insulin Resistance.Overview of metformin: special focus on metformin extended release.A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on Metformin.AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study.Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus.Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function.A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study.
P2860
Q24235718-E2A8A432-65D0-4CF1-A314-279974346044Q24240522-44F67F5D-AE0B-4C12-A2DB-097EEE7B5B59Q36390254-00B19C17-838F-4C67-B252-F1D4115440DBQ36465643-895B4704-2412-4E50-8BF7-93A82D238919Q36910592-C1E00E69-391E-448D-8DE8-BB43E07C9194Q37059366-4F93E26A-03AD-469C-976B-3187F5F424FDQ37583856-18C09F72-E55B-40D3-AAFC-457757C32D32Q38024861-CF7D06E8-7D8D-44B7-B828-6443C8254CD1Q39602527-03B99950-2A61-4FA1-9079-15D6E84F1C57Q39765196-2561B6EF-5909-4618-AE46-4F01A767D0FCQ42633482-A3797C81-447C-4D3A-A557-A7F26FBBCF33Q44242299-B8908CB2-E52A-45F0-BA6B-786DFA52C841Q48226343-BF6188AD-4F28-42AB-9106-82F069432E28
P2860
Population exposure-response modeling of metformin in patients with type 2 diabetes mellitus.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Population exposure-response m ...... with type 2 diabetes mellitus.
@en
Population exposure-response m ...... with type 2 diabetes mellitus.
@nl
type
label
Population exposure-response m ...... with type 2 diabetes mellitus.
@en
Population exposure-response m ...... with type 2 diabetes mellitus.
@nl
prefLabel
Population exposure-response m ...... with type 2 diabetes mellitus.
@en
Population exposure-response m ...... with type 2 diabetes mellitus.
@nl
P2093
P2860
P356
P1476
Population exposure-response m ...... with type 2 diabetes mellitus.
@en
P2093
Bahru Habtemariam
Donald E Mager
Joseph R Walker
Shashank Rohatagi
Sherwyn L Schwartz
P2860
P304
P356
10.1177/0091270008316884
P577
2008-03-27T00:00:00Z